Showing results (11-20 of 84) with videos related to

Sort By:
Pageof 9
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 14, 2003
Calculation of the risk of ovarian cancer from serial CA-125 values for preclinical detection in postmenopausal womenSteven J Skates, Usha Menon, Nicola MacDonald, et al.
Obstetrics and Gynecology|July 22, 2011
Evaluation of the diagnostic accuracy of the risk of ovarian malignancy algorithm in women with a pelvic massRichard G Moore, M Craig Miller, Paul Disilvestro, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 14, 2020
Biomarkers and Strategies for Early Detection of Ovarian CancerRobert C Bast, Zhen Lu, Chae Young Han, et al.
American Journal of Obstetrics and Gynecology|January 31, 2012
Serum HE4 levels are less frequently elevated than CA125 in women with benign gynecologic disordersRichard G Moore, Michael Craig Miller, Margaret M Steinhoff, et al.
Disease Markers|October 30, 2013
Comparison of the diagnostic accuracy of the MSLN gene products, mesothelin and megakaryocyte potentiating factor, as biomarkers for mesothelioma in pleural effusions and serumJenette Creaney, Sophie Sneddon, Ian M Dick, et al.
Investigative Radiology|October 22, 2024
Significance of Image Reconstruction Parameters for Future Lung Cancer Risk Prediction Using Low-Dose Chest Computed Tomography and the Open-Access Sybil AlgorithmJudit Simon, Peter Mikhael, Alexander Graur, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 16, 2007
Pooling of case specimens to create standard serum sets for screening cancer biomarkersSteven J Skates, Nora K Horick, Joseph M Moy, et al.
Gynecologic Oncology|December 3, 2014
Combining clinical assessment and the Risk of Ovarian Malignancy Algorithm for the prediction of ovarian cancerRichard G Moore, Douglas M Hawkins, M Craig Miller, et al.
Chest|July 25, 2007
Combined CA125 and mesothelin levels for the diagnosis of malignant mesotheliomaJenette Creaney, Ivonne van Bruggen, Michelle Hof, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 24, 2010
Serum mesothelin for early detection of asbestos-induced cancer malignant mesotheliomaJenette Creaney, Nola J Olsen, Fraser Brims, et al.
Pageof 9